Every immunoassay exploits the ability of an antibody (referred to as a primary antibody) to bind selectively to a particular target antigen, which is usually presented in a complex fluid such as serum, blood or urine, or in a solid matrix such as a slice of tissue, a cell monolayer, a nitrocellulose blot or a plastic microplate. The antibody, in conjunction with a label that provides measurability, allows the quantity and/or distribution of the antigen to be determined. Amy Adams, Technical Support and Customer Service Supervisor at Innova Biosciences, with Professor Paul J. Davis, Founder/CSO and Julie Thompson, Research scientist at Mologic focus on fast antibody conjugates.